IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH
IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA
FROM THE LARGE, REAL-WORLD PsABIO STUDY
IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA FROM THE LARGE, REAL-WORLD PsABIO STUDY
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2021
Συγγραφείς:
Gossec, L. Siebert, S. Bergmans, P. De Vlam, K. Gremese, E. Joven-Ibanez, B. Korotaeva, T. Noel, W. Nurmohamed, M. Sfikakis, P. Theander, E. Smolen, J. S.
